MHC — Myhealthchecked Share Price
Last trade - 00:00- £5.59m
- £0.62m
- £22.31m
- 49
- 96
- 17
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.65 | ||
| Price to Tang. Book | 0.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.37 | ||
| EV to EBITDA | 2.51 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.2% | ||
| Return on Equity | 2.22% | ||
| Operating Margin | 0.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 0 | 0.03 | 0.05 | 16.38 | 22.31 | n/a | n/a | 190.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -41.62 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MyHealthChecked PLC is a United Kingdom-based consumer home-testing healthcare company. The Company is the umbrella brand of a range of at-home rapid tests, as well as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and blood sample collection kits. The Company also provides COVID tests. The Company's multi-platform portfolio of tests offers users access to a variety of test types, sample collection options, and levels of analysis, enabling it to meet diverse customer needs. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analyzed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. All its business activity is underpinned by two distinct routes to market: business to business to consumer (B2B2C) and direct to consumer.
Directors
- Adam Reynolds NEC (59)
- Penelope Mccormick CEO
- David Davies CFO (44)
- Laura Moore NED (34)
- Neil Mesher NID (54)
- Lyn Rees NID (47)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- April 22nd, 2008
- Public Since
- July 5th, 2013
- No. of Employees
- 15
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 52,005,932
- Address
- The Maltings, East Tyndall Street, Wales, CARDIFF, CF24 5EA
- Web
- https://investors.myhealthchecked.com/
- Phone
- +44 2920351454
- Auditors
- Jeffreys Henry LLP
Latest News for MHC
Upcoming Events for MHC
Myhealthchecked PLC Annual Shareholders Meeting
Myhealthchecked PLC Annual Shareholders Meeting
Half Year 2024 Myhealthchecked PLC Earnings Release
Similar to MHC
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Advanced Oncotherapy
London Stock Exchange
Angle
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in Myhealthchecked are trading at 10.75p. This share price information is delayed by 15 minutes.
Shares in Myhealthchecked last closed at 10.75p and the price had moved by -43.79% over the past 365 days. In terms of relative price strength the Myhealthchecked share price has underperformed the FTSE All Share Index by -43.77% over the past year.
There is no consensus recommendation for this security.
Myhealthchecked does not currently pay a dividend.
Myhealthchecked does not currently pay a dividend.
Myhealthchecked does not currently pay a dividend.
To buy shares in Myhealthchecked you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 10.75p, shares in Myhealthchecked had a market capitalisation of £5.59m.
Here are the trading details for Myhealthchecked:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MHC
Based on an overall assessment of its quality, value and momentum Myhealthchecked is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Myhealthchecked. Over the past six months, its share price has underperformed the FTSE All Share Index by -24.87%.
As of the last closing price of 10.75p, shares in Myhealthchecked were trading -8.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Myhealthchecked PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 10.75p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Myhealthchecked's management team is headed by:
- Adam Reynolds - NEC
- Penelope Mccormick - CEO
- David Davies - CFO
- Laura Moore - NED
- Neil Mesher - NID
- Lyn Rees - NID